Terminál kontrast náklad genentech nik inhibitor canada Pence K meditaci Za rozbřesku
Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors - ScienceDirect
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis | Cell Death & Differentiation
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
A novel inhibitor of NF-κB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized mice - ScienceDirect
PDF) Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation - Shiode - Hepatology - Wiley Online Library
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NF-κB Signaling | NF-kappaB Pathway
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
Transcreener ADP Assay Enables Evaluation of NIK Inhibitors in Lupus Drug Discovery - BellBrook Labs
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. - Abstract - Europe PMC
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-k
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
The structure of Amgen NIK compounds. | Download Scientific Diagram
NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression | PLOS ONE
NIK compounds* inhibit NFkB activation mediated by Smac-mimetic in MM... | Download Scientific Diagram
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. - Abstract - Europe PMC
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A